How do patients with inflammatory bowel disease want their biological therapy administered?

BACKGROUND: Infliximab is usually administered by two monthly intravenous (iv) infusions, therefore requiring visits to hospital. Adalimumab is administered by self subcutaneous (sc) injections every other week. Both of these anti-TNF drugs appear to be equally efficacious in the treatment of Crohn&...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Patrick B, Lindsay, Hannah, Tham, Tony CK
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817682/
https://www.ncbi.nlm.nih.gov/pubmed/20064220
http://dx.doi.org/10.1186/1471-230X-10-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817682/
https://www.ncbi.nlm.nih.gov/pubmed/20064220
http://dx.doi.org/10.1186/1471-230X-10-1

Ejemplares similares